Health inequities in the diagnosis, treatment, and outcomes of gastrointestinal disorders significantly impact racial, ethnic, and immigrant populations. Patients born outside the U.S. are less likely to be diagnosed with inflammatory bowel disease (IBD) before age 16 and often face milder disease progression compared to U.S.-born patients. South Asian, Latine, and Asian patients in Western countries are at greater risk for IBD, suffering from more extensive inflammatory progression and facing challenges in accessing IBD specialists. Furthermore, patients of color report poor symptom control, lower quality of life, and greater financial and social challenges, which exacerbate disparities in IBD care.
In this CME Outfitters BriefCase, part of a collection on health equity, expert faculty will explore strategies to improve health equity in gastrointestinal care. The focus will be on understanding upstream, midstream, and downstream drivers of health inequities, such as socioeconomic status, immigration status, and lack of social support. Learners will gain actionable strategies, including utilizing case managers, interpreter services, culturally aligned dieticians, and community support workers to address social drivers of health. These strategies aim to improve diagnosis, treatment, and outcomes for underserved populations, fostering equitable gastrointestinal care delivery.
At the conclusion of this activity, learners will be able to better:
Supported by an educational grant provided by Johnson & Johnson.
Physicians specializing in gastroenterology, surgery, or primary care, physician associates (PAs), nurse practitioners (NPs), nurses, pharmacists, front office staff and administrators, finance staff, executives, support staff, and patients
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This application-based activity is approved for 1.00 contact hours (0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-24-069-H01-P).
This activity is designated for 1.00 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 08/29/2027. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Dr. Peek reports the following financial relationships:
Advisory Board: Abbott–Diabetes Health Equity Advisory Board (2022)
Dr. Nandi reports the following financial relationships:
Consultant: AbbVie Inc.; Boehringer-Ingelheim; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; and Pfizer Inc.
The following individuals have no financial relationships to disclose:
Rebecca Vargas-Jackson, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Thomas Mitchell, MSW (Planning Committee)
Keshia Pitt, PhD (Planning Committee)
Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Call us at 877.CME.PROS (877.263.7767).
BC-124-08294-57
